Jonathan J Mazelsky Appointed to the BOD of Insulet Corporation
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Insulet adds new board director
Jay Mazelsky, Insulet’s newest board member [Image from IDEXX]Insulet (Nasdaq:PODD) announced today that it appointed Jonathan (“Jay”) Mazelsky to its board of directors, effective July 1. Mazelsky joins the Acton, Massachusetts-based automated insulin delivery technology developer‘s board as an independent director. “We are pleased to welcome Jay to Insulet’s board of directors,” said Insulet President and CEO Ashley McEvoy. “Jay has a strong t…
Jonathan J Mazelsky Appointed to the BOD of Insulet Corporation
Jay Mazelsky: “Insulet has built a strong category-leading business based on Omnipod’s unique AID system, clinical evidence and real-world outcomes, and I am truly inspired by the Company’s relentless commitment to reduce the burden of diabetes. The post Jonathan J Mazelsky Appointed to the BOD of Insulet Corporation first appeared on Medical Device News Magazine.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
